U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry UNKNOWN
Molecular Formula C17H21NO
Molecular Weight 255.3547
Optical Activity ( + )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TOFENACIN, (+)-

SMILES

CNCCOC(C1=CC=CC=C1)C2=C(C)C=CC=C2

InChI

InChIKey=PNYKGCPSFKLFKA-UHFFFAOYSA-N
InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)17(19-13-12-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3

HIDE SMILES / InChI
Molecular Formula C17H21NO
Molecular Weight 255.3547
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Description

1-[3-(Benzyloxy)phenyl]-N,N-dimethylethanamine is an intermediate compound in the chemical synthesis of a drug Rivastigmine, which is used to treat Alzheimer's and Parkinson's disease.

Approval Year

Unknown
139594
Targets

Targets

Primary TargetPharmacologyConditionPotency
Antagonist
2778
PubMed

PubMed

TitleDatePubMed
A comparative trial of orphenadrine and tofenacin in the control of depression and extrapyramidal side-effects associated with fluphenazine decanoate therapy.
1976
Substance Class Chemical
Created
by admin
on Sat Dec 16 11:51:38 GMT 2023
Edited
by admin
on Sat Dec 16 11:51:38 GMT 2023
Record UNII
D67B6M43WW
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
TOFENACIN, (+)-
Common Name English
ETHYLAMINE, N-METHYL-2-((O-METHYL-.ALPHA.-PHENYLBENZYL)OXY)-, (+)-
Systematic Name English
Code System Code Type Description
PUBCHEM
25315
Created by admin on Sat Dec 16 11:51:38 GMT 2023 , Edited by admin on Sat Dec 16 11:51:38 GMT 2023
PRIMARY
FDA UNII
D67B6M43WW
Created by admin on Sat Dec 16 11:51:38 GMT 2023 , Edited by admin on Sat Dec 16 11:51:38 GMT 2023
PRIMARY
CAS
33431-05-9
Created by admin on Sat Dec 16 11:51:38 GMT 2023 , Edited by admin on Sat Dec 16 11:51:38 GMT 2023
PRIMARY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966